Literature DB >> 20528637

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics.

Julio D Duarte1, Rhonda M Cooper-DeHoff.   

Abstract

Thiazide and thiazide-like diuretics are among the most commonly used antihypertensives and have been available for over 50 years. However, the mechanism by which these drugs chronically lower blood pressure is poorly understood. Possible mechanisms include direct endothelial- or vascular smooth muscle-mediated vasodilation and indirect compensation to acute decreases in cardiac output. In addition, thiazides are associated with adverse metabolic effects, particularly hyperglycemia, and the mechanistic underpinnings of these effects are also poorly understood. Thiazide-induced hypokalemia, as well as other theories to explain these metabolic disturbances, including increased visceral adiposity, hyperuricemia, decreased glucose metabolism and pancreatic beta-cell hyperpolarization, may play a role. Understanding genetic variants with differential responses to thiazides could reveal new mechanistic candidates for future research to provide a more complete understanding of the blood pressure and metabolic response to thiazide diuretics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528637      PMCID: PMC2904515          DOI: 10.1586/erc.10.27

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  83 in total

1.  Acute and chronic effects of different concentrations of free fatty acids on the insulin secreting function of islets.

Authors:  G Ayvaz; F Balos Törüner; A Karakoç; I Yetkin; N Cakir; M Arslan
Journal:  Diabetes Metab       Date:  2002-12       Impact factor: 6.041

Review 2.  Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family.

Authors:  Steven C Hebert; David B Mount; Gerardo Gamba
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

5.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Authors:  Carl J Pepine; Eileen M Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter Kowey; Franz H Messerli; Giuseppe Mancia; José L Cangiano; David Garcia-Barreto; Matyas Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

6.  Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

Authors:  Lars H Lindholm; Mats Persson; Petar Alaupovic; Bo Carlberg; Anders Svensson; Ola Samuelsson
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

Review 7.  Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Authors:  Barry L Carter; Michael E Ernst; Jerome D Cohen
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

8.  Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.

Authors:  Doris M Tham; Baby Martin-McNulty; Yi-xin Wang; Dennis W Wilson; Ronald Vergona; Mark E Sullivan; William Dole; John C Rutledge
Journal:  Physiol Genomics       Date:  2002-10-02       Impact factor: 3.107

9.  Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  Ken Williams; Allan D Sniderman; Naveed Sattar; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

Review 10.  Diuretic-related side effects: development and treatment.

Authors:  Doemnic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738

View more
  53 in total

1.  Antihypertensive medications and physical function in older persons.

Authors:  Carlos A Vaz Fragoso; Gail J McAvay
Journal:  Exp Gerontol       Date:  2020-06-25       Impact factor: 4.032

Review 2.  Tolerability of Antihypertensive Medications in Older Adults.

Authors:  Thiruvinvamalai S Dharmarajan; Lekshmi Dharmarajan
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

3.  Activation of human smooth muscle BK channels by hydrochlorothiazide requires cell integrity and the presence of BK β1 subunit.

Authors:  Pedro Martín; Melisa Moncada; Guruprasad Kuntamallappanavar; Alex M Dopico; Verónica Milesi
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

4.  Constipation in older adults: stepwise approach to keep things moving.

Authors:  Brenda G Schuster; Lynette Kosar; Rejina Kamrul
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

5.  Lack of thiazide diuretic inhibition of agonist constriction of mouse mesenteric arterioles ex vivo.

Authors:  Robert M Rapoport; Amanda J LeBlanc; Jason E Beare; Manoocher Soleimani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-23       Impact factor: 3.000

Review 6.  New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Authors:  Erik R Swenson
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 7.  Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.

Authors:  Eric Judd; Edgar A Jaimes
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-03

8.  Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients.

Authors:  Yoshiyuki Okada; Shigeki Shibata; Naoki Fujimoto; Stuart A Best; Benjamin D Levine; Qi Fu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-19       Impact factor: 3.619

Review 9.  Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.

Authors:  Feras Karadsheh; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 10.  Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials.

Authors:  Jill J Hall; Dean T Eurich; Danielle Nagy; Lisa Tjosvold; John-Michael Gamble
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.